Impaired platelet aggregation
|
phenotype |
|
Finding
|
16
|
|
0.100 |
None |
|
0 |
|
|
|
Prolonged whole-blood clotting time
|
phenotype |
Hemic and Lymphatic Diseases
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Prolonged bleeding time
|
phenotype |
|
Finding
|
39
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Hemarthrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Pathologic Function
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
VON WILLEBRAND FACTOR VICENZA PHENOTYPE
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Urogenital Abnormalities
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Congenital Abnormality
|
42
|
3
|
0.100 |
None |
|
0 |
|
|
|
Epistaxis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Pathologic Function
|
82
|
4
|
0.100 |
None |
|
0 |
|
|
|
VON WILLEBRAND DISEASE, TYPE 1, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Variable expressivity
|
phenotype |
|
Finding
|
319
|
|
0.100 |
None |
|
0 |
|
|
|
Prolonged bleeding after surgery
|
phenotype |
|
Pathologic Function
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Persistent bleeding after trauma
|
phenotype |
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Reduced quantity of Von Willebrand factor
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Increased tendency to bruise
|
phenotype |
Wounds and Injuries
|
Finding
|
133
|
14
|
0.100 |
None |
|
0 |
|
|
|
Reduced von Willebrand factor activity
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Mitral Valve Prolapse Syndrome
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
111
|
29
|
0.100 |
None |
|
0 |
|
|
|
Menorrhagia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
34
|
6
|
0.100 |
None |
|
0 |
|
|
|
Reduced factor VIII activity
|
phenotype |
|
Finding
|
4
|
1
|
0.100 |
None |
|
0 |
|
|
|
Gastric Varix
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Aortic Aneurysm, Abdominal
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
586
|
90
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Cystic Fibrosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
852
|
704
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |
Photopsia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
35
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Proliferative retinopathy
|
disease |
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
57
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Melioidosis
|
disease |
Infections
|
Disease or Syndrome
|
65
|
9
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Aortic valve calcification
|
disease |
Nutritional and Metabolic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
79
|
4
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
209
|
37
|
0.020 |
None |
0.500 |
2 |
1
|
2003 |
2013 |